Zidovudine

CAS No. 30516-87-1

Zidovudine( Azidothymidine | AZT | ZDV )

Catalog No. M13969 CAS No. 30516-87-1

A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 40 In Stock
100MG 52 In Stock
200MG 68 In Stock
500MG 117 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Zidovudine
  • Note
    Research use only, not for human use.
  • Brief Description
    A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.
  • Description
    A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.HIV Infection Approved.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Azidothymidine | AZT | ZDV
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    ReverseTranscriptase|Telomerasereversetranscriptase
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    30516-87-1
  • Formula Weight
    267.2413
  • Molecular Formula
    C10H13N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 2.7 mg/mL
  • SMILES
    O=C1NC(C(C)=CN1[C@@H]2O[C@H](CO)[C@@H](N=[N+]=[N-])C2)=O
  • Chemical Name
    Thymidine, 3'-azido-3'-deoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pirmitegravir

    Pirmitegravir (STP0404) is a potent and selective inhibitor of allosteric integrase (ALLINI) targeting the LEDGF/p75 binding site. Pirmitegravir inhibits PBMC.

  • HIV-1 Rev 34-50

    HIV-1 Rev (34-50) is a 17-aa peptide derived from the Rev-responsive element (RRE)-binding domains of Rev in HIV-1, with anti-HIV-1 activity. HIV-1 Rev peptide is a one of the cell-penetrating peptides (CPPs) derived from HIV-1 Rev protein residue 34-50. It is a RNA binding peptideand has been used to deliver macromolecules into cells.

  • Tipranavir

    Tipranavir is a protease inhibitor that inhibits HIV-1 resistant to more than 1 protease inhibitor .